Other potential limitations include assessing for pLoF in oncogenic candidates such as RET, ROS1, FGFR4, and MYC, while FAT1 and LEF1 reported to oscillate between oncogenic and tumour suppressive behaviour. Here, FAT1 is linked to neoplasm.